Company intelligence / Profile preview

Ace Japan

Funabashi, Chiba, Japan

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Ace Japan Co., Ltd. is a specialized Japanese contract research organization (CRO) and contract development and manufacturing organization (CDMO) that provides high-level synthetic organic chemistry services. The company is primarily focused on supporting the early-to-late stages of drug discovery through the custom synthesis of lead compounds, intermediates, and building blocks. It is particularly recognized for its technical expertise in stable isotope labeling (using Deuterium, Carbon-13, and Nitrogen-15) and the synthesis of metabolites and impurities for pharmaceutical analysis.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Ace Japan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ace Japan.

Explore the full profile